Ishii, Hitoshi http://orcid.org/0000-0002-6214-0557
Maeda, Yasutaka http://orcid.org/0000-0002-3259-5622
Sato, Manaka http://orcid.org/0000-0001-7000-4769
Cai, Zhihong http://orcid.org/0000-0002-3431-197X
Imori, Makoto
Article History
Received: 14 November 2023
Accepted: 15 March 2024
First Online: 18 May 2024
Declarations
:
: Hitoshi Ishii declares lecture fees from Eli Lilly Japan K.K., Novo Nordisk, MSD K.K., and Sumitomo Pharma Co. Ltd. Manaka Sato, Zhihong Cai, and Makoto Imori are employees of Eli Lilly Japan K.K., and are minor stockholders of Eli Lilly and Company. Yasutaka Maeda has nothing to declare.
: The study was conducted in accordance with the Declaration of Helsinki of 1964 and its later amendments, and is consistent with Ethical Guidelines for Medical and Biological Research Involving Human Subjects, and Japanese laws and regulations. The study was approved by the Takahashi Clinic Ethics Committee (approval number: LNW00171). All participants provided electronic informed consent to participate in the study and for the publication of the study results.